Ovarian Cancer Precision Medicine
Find strength through Appleglc.com’s ovarian cancer hub, featuring PARP inhibitor guidance, platinum-based chemotherapy protocols, and bevacizumab-based treatment planning support.
Imfinzi
Durvalumab
Zejula
Niraparib
Alimta
Pemetrexed
Adrucil
Fluorouracil
Herzuma
Trastuzumab-pkrb
Elahere
Mirvetuximab Soravtansine-gynx
Mirvetuximab Soravtansine IV
Mirvetuximab Soravtansine-gynx
Lynparza
Olaparib
Rubraca
Rucaparib
Alymsys
Bevacizumab-maly
Avastin
Bevacizumab
Zirabev
Bevacizumab-bvzr
Vegzelma
Bevacizumab-adcd
Abevmy
Bevacizumab-mrba
Mvasi
Bevacizumab-awwb
Mektovi
Binimetinib
Cotellic
Cobimetinib
Mekinist
Trametinib
Tafinlar
Dabrafenib
Opdivo
Nivolumab
Keytruda
Pembrolizumab
Yervoy
Ipilimumab
Trodelvy
Sacituzumab Govitecan-hziy
Zynyz
Retifanlimab-dlwr
Imlygic
Talimogene Laherparepvec
Proleukin
Aldesleukin
Aldesleukin IV
Aldesleukin
Rozlytrek
Entrectinib
Retevmo
Selpercatinib
Cabometyx
Cabozantinib
Lenvima
Lenvatinib
Kisqali
Ribociclib
Verzenio
Abemaciclib
Ibrance
Palbociclib
Orserdu
Elacestrant
Doxil
Doxorubicin Hydrochloride Liposome
Alkeran
Melphalan
Paraplatin
Carboplatin
Platinol
Cisplatin
Cytoxan
Cyclophosphamide